Volunteer's death in Bhopal not related to our vaccine: Bharat Biotech
PTI
Updated : Jan 10, 2021, 10:06 am IST
The volunteer was reported to be healthy in all the site follow-up calls post seven days of his dosing, the vaccine maker said
There are several factors that can cause an adverse event during a clinical trial, including the patient's underlying disease, other pre-existing conditions or any other unrelated occurrence like an accident, Bharat Biotech said. (Representational Image: AFP)
Volunteer's death in Bhopal not related to our vaccine: Bharat Biotech
New Delhi: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.